Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors

por Wong, Jeffrey Sum Lung, Kwok, Gerry Gin Wai, Tang, Vikki, Li, Bryan Cho Wing, Leung, Roland, Chiu, Joanne, Ma, Ka Wing, She, Wong Hoi, Tsang, Josephine, Lo, Chung Mau, Cheung, Tan To, Yau, Thomas
Publicado 2021

Predicting Dynamic Clinical Outcomes of the Chemotherapy for Canine Lymphoma Patients Using a Machine Learning Model

por Koo, Jamin, Choi, Kyucheol, Lee, Peter, Polley, Amanda, Pudupakam, Raghavendra Sumanth, Tsang, Josephine, Fernandez, Elmer, Han, Enyang James, Park, Stanley, Swartzfager, Deanna, Qi, Nicholas Seah Xi, Jung, Melody, Ocnean, Mary, Kim, Hyun Uk, Lim, Sungwon
Publicado 2021

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model

por Bohannan, Zach, Pudupakam, Raghavendra Sumanth, Koo, Jamin, Horwitz, Harrison, Tsang, Josephine, Polley, Amanda, Han, Enyang James, Fernandez, Elmer, Park, Stanley, Swartzfager, Deanna, Qi, Nicholas Seah Xi, Tu, Chantal, Rankin, Wendi Velando, Thamm, Douglas H., Lee, Hye‐Ryeon, Lim, Sungwon
Publicado 2020

The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong—A Territory-Wide Cohort Study

por Wong, Jeffrey Sum-Lung, Dong, Yawen, Tang, Vikki, Leung, Thomas, Yeung, Cynthia S. Y., Tai, Anna, Law, Ada, Shum, Tracy, Kwok, Gerry Gin-Wai, Li, Bryan Cho-Wing, Leung, Roland, Chiu, Joanne, Ma, Ka-Wing, She, Wong-Hoi, Tsang, Josephine, Cheung, Tan-To, Yau, Thomas
Publicado 2021